Your browser doesn't support javascript.
loading
Adhesion molecules in multiple myeloma oncogenesis and targeted therapy.
Bou Zerdan, Maroun; Nasr, Lewis; Kassab, Joseph; Saba, Ludovic; Ghossein, Myriam; Yaghi, Marita; Dominguez, Barbara; Chaulagain, Chakra P.
Afiliação
  • Bou Zerdan M; Department of Hematology-Oncology, Myeloma & Amyloidosis Program, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL 33331, USA.
  • Nasr L; Saint-Joseph University, Faculty of Medicine, Beirut, Lebanon.
  • Kassab J; Saint-Joseph University, Faculty of Medicine, Beirut, Lebanon.
  • Saba L; Saint-Joseph University, Faculty of Medicine, Beirut, Lebanon.
  • Ghossein M; Department of Medicine & Medical Sciences, University of Balamand, Balamand, Lebanon.
  • Yaghi M; Department of Hematology-Oncology, Myeloma & Amyloidosis Program, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL 33331, USA.
  • Dominguez B; Department of Hematology-Oncology, Myeloma & Amyloidosis Program, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL 33331, USA.
  • Chaulagain CP; Department of Hematology-Oncology, Myeloma & Amyloidosis Program, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL 33331, USA.
Int J Hematol Oncol ; 11(2): IJH39, 2022 Apr.
Article em En | MEDLINE | ID: mdl-35663420
ABSTRACT
Every day we march closer to finding the cure for multiple myeloma. The myeloma cells inflict their damage through specialized cellular meshwork and cytokines system. Implicit in these interactions are cellular adhesion molecules and their regulators which include but are not limited to integrins and syndecan-1/CD138, immunoglobulin superfamily cell adhesion molecules, such as CD44, cadherins such as N-cadherin, and selectins, such as E-selectin. Several adhesion molecules are respectively involved in myelomagenesis such as in the transition from the precursor disorder monoclonal gammopathy of undetermined significance to indolent asymptomatic multiple myeloma (smoldering myeloma) then to active multiple myeloma or primary plasma cell leukemia, and in the pathological manifestations of multiple myeloma.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int J Hematol Oncol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int J Hematol Oncol Ano de publicação: 2022 Tipo de documento: Article